The economic burden of glaucoma on patients
- PMID: 36727360
- PMCID: PMC10228918
- DOI: 10.4103/ijo.IJO_1676_22
The economic burden of glaucoma on patients
Abstract
Purpose: To determine the economic burden of glaucoma on patients.
Methods: A cross-sectional study was conducted on glaucoma patients diagnosed at least 6 weeks prior to the study and on topical anti-glaucoma medications. After consenting, patients were asked about their monthly income, education, occupation, treatment duration, drugs being used, cost of drugs, one bottle lasts for, financial dependence for treatment, glaucoma surgery, transportation means and cost, etc. Also, information regarding government reimbursement of medical costs was collected.
Results: Seventy-four patients aged 60.18±11.5 years (40 males and 34 females) were enrolled. Majority were retirees (37.84%) and Homemakers (29.73%). Fifty (68%) participants didn't earn anything. Sixty-three patients had bilateral involvement and 52.70% were on treatment for >3 years. Prostaglandin analogs were most commonly used drugs (34.21%). Average cost of medications and travelling was ₹669.46 per month and ₹203.38 per visit respectively. Majority were financially responsible for their own treatment (62.16%). Patients had an average monthly income of ₹7108.11. Low-income group spent 26.08 % of their monthly salary on glaucoma treatment. Low-moderate and high-income group spent 5.17% and 1.50% of their monthly income respectively. Only 4.05% were covered by government reimbursement. Gender (P=0.019), occupation (P=0.010), whether undergone surgery (P=0.007), whether accompanied (P=0.027), hours lost during each visit (P=0.016) and treatment impression (P=0.027) showed statistical significance when associated with financial dependence.
Conclusion: Treatment should be modified according to the patient's socioeconomic status. Glaucoma education programs and screening camps in remote areas would help in early detection of the disease.
Keywords: Burden; compliance; glaucoma.
Conflict of interest statement
None
Comment in
-
Commentary: Minimally invasive glaucoma surgery for a surgical take diversion: An economic perspective.Indian J Ophthalmol. 2023 Feb;71(2):566-568. doi: 10.4103/ijo.IJO_2264_22. Indian J Ophthalmol. 2023. PMID: 36727361 Free PMC article. No abstract available.
References
-
- Rouland JF, Berdeaux G, Lafuma A. The economic burden of glaucoma and ocular hypertension:Implications for patient management:A review. Drugs Aging. 2005;22:315–21. - PubMed
-
- Ahmad A, Ahmad SZ, Khalique N, Ashraf M, Alvi Y. Prevalence and associated risk factors of glaucoma in Aligarh, India –A population based study. DJO. 2020;31:36–40.
-
- Tham YC, Li X, Wong TY, Quigley HA, Aung T, Cheng CY, et al. Global prevalence of glaucoma and projections of glaucoma burden through 2040:A systematic review and meta-analysis. Ophthalmology. 2014;121:2081–90. - PubMed
-
- Khandelwal RR, Raje D, Khandelwal RR. Clinical profile and burden of primary glaucoma in rural camp patients attending a tertiary care center in India. J Clin Ophthalmol Res. 2019;7:55–60.
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
